Proceeding contribution from Ian Gibson (Labour) in the House of Commons on Monday, 12 May 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill.
Human Fertilisation and Embryology Bill
I believe that this is a skirmish in comparison with what will happen next Monday and Tuesday, when we deal with the nitty-gritty of some of these issues. We shall be able to have a real argy-bargy. I am sure that many of us have argued about the issues for 100 years and more, in cold flats, in universities and in schools. They have not gone away, and many of them are not new. All these questions—what is life, when is an embryo a gamete, what is the role of our maker—have been around for a long time. I should declare a couple of interests. As was pointed out by my hon. Friend the Member for Bolton, South-East (Dr. Iddon), I chaired the Select Committee. We had epic discussions, and we split, not amicably. I earned a reputation as Dr. Frankenstein, according to my hon. Friend the Member for Morecambe and Lunesdale (Geraldine Smith), and I have loved and lived that reputation ever since. I am also a member of the Stem Cell Foundation, which is part of a Medical Research Council unit. It contains some distinguished individuals who are interested in promoting the foundation, which was established in 2005 to support the advance of pioneering stem cell research into medical practice. We receive many private donations. So far we have received some £90 million, and we hope that when stem cell work starts to break through we shall be able to develop it in this country. Many of us remember what happened when monoclonal antibodies were discovered at Cambridge. The work was taken to the United States, and millions of people, as well as industries, benefited from our discoveries. I am very pleased to be continuing the stem cell work. As with everything in science, we live in hope that something will happen, but it is never possible to swear to it. I am 99.9 per cent. sure that the sun will rise tomorrow morning, but who knows? Something just might happen. We live in a world in which interesting things turn up in science, and that is why we become involved. We want an environment in which we can research and find things out. I remember when, in the 1970s, we discussed genetic recombinant DNA. There were huge fights and marches in Boston to protest against the insertion of animal DNA into human cells and vice versa. It was the scientists themselves who regulated the position and determined the category into which the work should fall. They have now established the principle, and people carry out such work all the time. For example, human insulin and bacteria are made in animal cells, to the benefit of many people who suffer from diabetes. Science was what motivated us to examine the issue in 2004, but we knew that there was a public out there who had been involved in the debates about in vitro fertilisation, and much of what is being said now was said about it then. All the same words and phrases were used, such as ““unnatural”” and ““playing God””. Now in vitro fertilisation is standard practice, and we are talking of improvements that ought to be made. We should be pressurising the system to ensure that it is available to people, because having a child is very much part of being a human being, and wanting a healthy child is particularly so. There will be much more in medicine that will—I hope—really tax this place, feeding the need for Committees and debates. It is estimated that by 2012 everyone will be able to have their DNA examined for $10 and be told whether they are likely to suffer from diseases such as Alzheimer's, if they want to know. Such information could be seen as intrusive by those who prefer to accept that life is a hazard and not to know what will happen, but it will be available. Jim Watson, the Nobel prize winner, has just had his DNA examined, but he refused to allow the part that might predict Alzheimer's to be examined, because he has reached the age at which it might happen and he was not sure whether he could handle the knowledge emotionally. Very interesting developments are in prospect, and, as has been said before, we must be ahead of the curve and ensure we have the necessary legislation. Members have referred to the work in Japan. My hon. Friend the Member for Bolton, South-East mentioned the oncogene, which might be involved in the development of cancers—Nobel prize-winning stuff again—and might be carried by retroviruses when they are put into a particular cell. That is the problem with gene therapy—trying to change genetic problems by inserting DNA. We do not yet have a foolproof mechanism for the use of retrovirusues, although scientists are trying to find other ways of getting genes into adult cells while preventing the development of cancers. Not all scientists agree with this type of work. For example, in an article entitled, ““The Production of Admixed Animal-Human Embryos: Is it Necessary, or Merely Desirable?””, Professor Michael Balls—a familiar name in this place—from FRAME, an organisation that tries to stop animals being used in medical research, questions the partial arrogance of science in wanting to do such things. Therefore, scientists do argue about whether this is a valid procedure in conference centres and debating halls—as I said, we have managed to hammer out the issue of recombinant DNA. My bet is that the scientific community, including the medics, and the public—when they are engaged—will be able to say what they think about these embryos. Admixed embryos are not new. Indeed, I remember merging mouse cells and human cells and getting chromosomes—genetic material—from mice and humans. A competition went on between them, and the cells and chromosomes that developed were mainly human. As a result, we found out about matters such as which DNA genes and chromosomes were next to each other. That has now developed into the human genome field, which has so much potential in developing our attitudes on, and knowledge of, health. As there were admixed embryos in the past, I think there will continue to be such embryos. We need the potential for making stem cells. Some stem cells at certain layers in the blastocyst are better at developing than others. Some people say, ““Embryonic stem cells haven't done anything.”” That is not quite true. We have to go through very strong safety conditions and procedures, and we use mice and rats. People might be against that experimentation, too, but it is the law and it has to be followed. Certain situations, such as where there are model mental health problems in mice or rats, can be corrected by injecting embryonic stem cells.
Secondary information
- Type
- Proceeding contribution
- Reference
- 475 c1109-11
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Civil partnerships Clones Abortion Blood Fertility Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Discrimination Foetal tissue NHS Medical treatments Screening Religion Sexuality Research Stem cells Christianity Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 00:26:00 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_471614
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_471614
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_471614